Lv4
486 积分 2023-09-11 加入
p95HER2, a truncated form of the HER2 oncoprotein, drives an immunosuppressive program in HER2+ breast cancer that limits trastuzumab deruxtecan efficacy
11小时前
待确认
A Phase I Study of the Anti-CEACAM6 Antibody Tinurilimab (BAY 1834942) in Patients with Advanced Solid Tumors
3天前
已完结
Investigation of the enhanced antitumour potency of CD46-specific chimeric antigen receptor-T cells in human colorectal cancer liver metastases after combination with nanotherapeutics
3个月前
已完结
CD46 Antibody Drug Conjugate Impedes Myeloma Engraftment in Patient-Derived Xenografts
3个月前
已完结
P-225: A first-in-human study of FOR46 in patients with triple refractory Multiple Myeloma
3个月前
已完结
Phase I, First-in-Human Study of FOR46 (FG-3246), an Immune-Modulating Antibody-Drug Conjugate Targeting CD46, in Patients With Metastatic Castration-Resistant Prostate Cancer
3个月前
已完结
TREM1 activation of myeloid cells promotes antitumor immunity
1年前
已完结
CD300ld on neutrophils is required for tumour-driven immune suppression
1年前
已完结
皖公网安备34019202002308
